Belgium – Various medicinal products – Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
Open call for tenders published in the EU Official Journal. Closes in 28 days.
Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
- Buyer
- IMELDA VZW
- Country
- Belgium
- Submission deadline
- 01 Dec 2026
- Contract type
- Supplies
- Sector (CPV)
- Medical equipment and pharmaceuticals
- Main CPV code
- 33690000
- Place of performance
- BE212
- Published
- 2026-11-03
- TED reference
- 763149-2026
Read the official notice on TED →
Rather not check this page every morning?
Follow new tenders with the free RSS feeds, CSV exports or JSON API.
Follow updates